Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections
Authors:
- 10 June 2023
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (2) , 106885
Abstract
No abstract availableKeywords
Funding Information
- Ministère des Affaires Sociales et de la Santé
- French Government Ministry of Social Affairs Health and Womens Rights (PHRC-I 14-025)
- Assistance publique-Hôpitaux de Paris (AOR14027)
This publication has 34 references indexed in Scilit:
- Rifampin Combination Therapy for Nonmycobacterial InfectionsClinical Microbiology Reviews, 2010
- Continuous Clindamycin Infusion, an Innovative Approach to Treating Bone and Joint InfectionsAntimicrobial Agents and Chemotherapy, 2010
- Handling Data Below the Limit of Quantification in Mixed Effect ModelsThe AAPS Journal, 2009
- Bactericidal Activity of the Combination of Levofloxacin with Rifampin in Experimental Prosthetic Knee Infection in Rabbits Due to Methicillin-Susceptible Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Antimicrobial Agents in Orthopaedic SurgeryDrugs, 2006
- IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESDrug Metabolism and Disposition, 2003
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin againstStaphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1986
- Effects of clindamycin in combination with rifampicin on clindamycin-susceptible and clindamycin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1985
- Clindamycin Dose-Bioavailability RelationshipsJournal of Pharmaceutical Sciences, 1973